Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder
| dc.contributor.author | Kuloglu, Murat | |
| dc.contributor.author | Atmaca, Murad | |
| dc.contributor.author | Onal, Suleyman | |
| dc.contributor.author | Gecici, Omer | |
| dc.contributor.author | Bulut, Vedat | |
| dc.contributor.author | Tezcan, Ertan | |
| dc.date.accessioned | 2026-08-12T17:44:57Z | |
| dc.date.issued | 2007 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Neopterin, a biopterin precursor that is released by macrophages, is an important immunological marker in psychiatric disorders. It has been reported that glucocorticoids may cause suppression of cell-mediated immunity and consequently result in decreased neopterin levels. In the present study, we evaluated whether dexamethasone suppression test (DST) and neopterin findings were associated with pure obsessive-compulsive disorder (OCD) patients (OCD-D group) and the concomitant OCD and depression (OCD+D group). The sample comprised 44 patients with OCD (27 with OCD-D and 17 with OCD+D) and 30 control subjects. There was significantly higher DST nonsuppression in the OCD+D group than in the OCD-D group. With regard to mean neopterin levels, there was no significant difference between the OCD-D group and the control group, but there was a statistically significant difference between the OCD+D group and the control group. The OCD+D group had significantly lower neopterin levels than the 20 OCD-D group. We suggest that this distinction may reflect the fact that glucocorticoids can lead to suppression of cell-mediated immunity and consequently can result in decreased neopterin levels. In conclusion, our results suggest that not the OCD-D group had normal neopterin levels and DST results, and also that OCD may be a heterogeneous subtype characterized by some biological indicators or anxiety and affective disorders. (c) 2006 Elsevier Ireland Ltd. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.psychres.2002.04.001 | |
| dc.identifier.endpage | 270 | |
| dc.identifier.issn | 0165-1781 | |
| dc.identifier.issue | 3 | |
| dc.identifier.orcid | 0000-0002-0508-2127 | |
| dc.identifier.pmid | 17467061 | |
| dc.identifier.scopus | 2-s2.0-34249700836 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 265 | |
| dc.identifier.uri | https://doi.org/10.1016/j.psychres.2002.04.001 | |
| dc.identifier.uri | https://hdl.handle.net/11508/60465 | |
| dc.identifier.volume | 151 | |
| dc.identifier.wos | WOS:000247650800011 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ireland Ltd | |
| dc.relation.ispartof | Psychiatry Research | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | OCD | |
| dc.subject | neopterin | |
| dc.subject | DST | |
| dc.subject | depression | |
| dc.title | Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder | |
| dc.type | Article |







